By NewsDesk @infectiousdiseasenews
The Philippines Department of Health (DOH) reported 4,339 new COVID-19 cases Thursday, including 2,590 cases in Metro Manila, bringing the country total to 178,022–the most in southeast Asia.
Eighty-eight additional COVID-19 related deaths were also recorded today, putting the Philippines death toll at 2,883.
On Wednesday, the Department of Science and Technology (DOST) stated that clinical trials on a COVID-19 vaccine will start in the country toward the end of the year and will likely be available in the Philippines by the second quarter of 2021.
DOST Undersecretary Rowena Cristina Guevara, chair of the Inter-Agency Task Force’s sub-technical working group on vaccine development, said the clinical trials would involve not just the vaccine made in Russia, but also those pre-qualified by the World Health Organization (WHO) as part of the Solidarity Trial.
Earlier, she said the Philippines will undertake the clinical trials Phase 3 for four or five vaccines that are pre-qualified by WHO. Moreover, the DOST is pursuing collaboration with bilateral partners, whereby vaccine companies may undertake clinical trial Phase 3 in the country.
- Massachusetts General Hospital researchers show children are silent spreaders of SARS-CoV-2
- Massachusetts confirmed 3rd human EEE case
- Peaches Linked to Multi-State Salmonella Outbreak
- Wound botulism case reported in Bernalillo County, New Mexico
- Multistate outbreak of Salmonella Newport infections linked to onions grows to 869 cases
- India averaging 60K COVID-19 cases during past two weeks
- Vibrio parahaemolyticus: UT Southwestern scientists discover pathway bacteria break out of cells